Standout Papers
- Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis (2004)
- mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt (2006)
- Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors (2000)
- Impaired recruitment of bone-marrow–derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth (2001)
- VEGF-targeted therapy: mechanisms of anti-tumour activity (2008)
- Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors (2005)
- Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose (2008)
- Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation (2004)
- Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity (2000)
- Escape of Human Solid Tumors from T–Cell Recognition: Molecular Mechanisms and Functional Significance (1999)
- Vascular Normalization by Vascular Endothelial Growth Factor Receptor 2 Blockade Induces a Pressure Gradient Across the Vasculature and Improves Drug Penetration in Tumors (2004)
- Vascular Trauma Induces Rapid but Transient Mobilization of VEGFR2 + AC133 + Endothelial Precursor Cells (2001)
- Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis (2003)
- Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiationRole of oxygenation, angiopoietin-1, and matrix metalloproteinases (2004)
- Vascular Endothelial Growth Factor and Angiopoietin-1 Stimulate Postnatal Hematopoiesis by Recruitment of Vasculogenic and Hematopoietic Stem Cells (2001)
- Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation (2005)
Immediate Impact
3 by Nobel laureates 40 from Science/Nature 193 standout
Citing Papers
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Works of Daniel J. Hicklin being referenced
Escape of Human Solid Tumors from T–Cell Recognition: Molecular Mechanisms and Functional Significance
1999 Standout
beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma.
1998
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Daniel J. Hicklin | 20563 | 13904 | 8709 | 184 | 34.9k | |
| Robert S. Kerbel | 24243 | 16351 | 13246 | 398 | 41.1k | |
| Harold L. Moses | 24171 | 14456 | 6445 | 311 | 40.1k | |
| Amato J. Giaccia | 22859 | 10629 | 17174 | 346 | 39.7k | |
| David A. Cheresh | 28065 | 10157 | 10443 | 241 | 48.0k | |
| Lynn M. Matrisian | 15089 | 17181 | 15625 | 254 | 37.8k | |
| Kevin C. Gatter | 12587 | 8164 | 8262 | 309 | 26.5k | |
| Shahin Rafii | 21138 | 10683 | 6814 | 302 | 38.4k | |
| David A. Tuveson | 19285 | 20810 | 9180 | 200 | 40.1k | |
| Daniel Birnbaum | 17111 | 12576 | 7426 | 550 | 31.2k | |
| Lena Claesson‐Welsh | 22006 | 6841 | 5707 | 253 | 31.8k |
All Works
Login with ORCID to disown or claim papers
Loading papers...